New study led by Queen Mary University of London finds no evidence that e-cigarettes act as a gateway to smoking at the population level. The research also suggests that alternative nicotine products may be competing against cigarettes, potentially accelerating the decline in smoking, although more data is needed for confirmation.
Experts applaud Amylyx for keeping its promise to withdraw ALS drug Relyvrio after trial failure
When Amylyx brought its ALS drug before the FDA in 2022, the biotech faced questions about what it would do if a crucial Phase 3
April 5, 2024